Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GCS002c
- Development stage
- Preclinical
- Lead developer
- Glen Clova Scientific
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Injection
01
Overview
GCS002c is a virus-like particle (VLP)-based protein vaccine being developed by Glen Clova Scientific for the treatment of canine atopic dermatitis. The vaccine is designed to induce the production of neutralizing antibodies against interleukin-13 (IL-13), a key Th2 cytokine that plays a central role in the pathogenesis of allergic skin diseases in dogs. By stimulating the animal's own immune system to target IL-13, GCS002c aims to provide a long-acting therapeutic alternative to monoclonal antibodies, potentially offering improved convenience and cost-effectiveness for the management of chronic atopic dermatitis in veterinary patients.
02
Targets
Beyond the preview
Go deeper on GCS002c.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GCS002c.